Results
1 -
10 of
12
(Click
here to explore results)
Emerging degrader technologies engaging lysosomal pathways . Yu Ding, Dong Xing, Yiyan Fei, Boxun Lu
, Chem. Soc. Rev.
, 2022
, 51
, 8832
Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy . Junping Pei, Xiaoli Pan, Aoxue Wang, Wen Shuai, Faqian Bu, Pan Tang, Shuai Zhang, Yiwen Zhang, Guan Wang, Liang Ouyang
, Chem. Commun.
, 2021
, 57
, 13194
Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR . Qingwen Zhang, Yuanyuan Diao, Fei Wang, Ying Fu, Fei Tang, Qidong You, Houyuan Zhou
, Med. Chem. Commun.
, 2013
, 4
, 979
Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments . Cheri Y. Li, David K. Wood, Joanne H. Huang, Sangeeta N. Bhatia
, Lab Chip
, 2013
, 13
, 1969
Improvement of high-glucose and insulin resistance of chromium malate in 3T3-L1 adipocytes by glucose uptake and insulin sensitivity signaling pathways and its mechanism . Weiwei Feng, Yongchao Liu, Fan Fei, Yao Chen, Yangyang Ding, Mengjiao Yan, Yun Feng, Ting Zhao, Guanghua Mao, Liuqing Yang, Xiangyang Wu
, RSC Adv.
, 2019
, 9
, 114
Integrating docking scores and key interaction profiles to improve the accuracy of molecular docking: towards novel B-RafV600E inhibitors . Chun-Qi Hu, Kang Li, Ting-Ting Yao, Yong-Zhou Hu, Hua-Zhou Ying, Xiao-Wu Dong
, Med. Chem. Commun.
, 2017
, 8
, 1835
Targeted protein degradation using the lysosomal pathway . Samrajni Ghosh, Bhavana Ramadas, Debasish Manna
, RSC Med. Chem.
, 2022
, 13
, 1476
Encoding BRAF inhibitor functions in protein degraders . Daniel S. J. Miller, Sabine A. Voell, Izidor Sosič, Matic Proj, Olivia W. Rossanese, Gregor Schnakenburg, Michael Gütschow, Ian Collins, Christian Steinebach
, RSC Med. Chem.
, 2022
, 13
, 731
Discriminatory analysis based molecular docking study for in silico identification of epigallocatechin-3-gallate (EGCG) derivatives as B-RafV600E inhibitors . Huazhou Ying, Jiangfeng Xie, Xingguo Liu, Tingting Yao, Xiaowu Dong, Chunqi Hu
, RSC Adv.
, 2017
, 7
, 44820
Hydroxybenzylidene-indolinones, c-di-AMP synthase inhibitors, have antibacterial and anti-biofilm activities and also re-sensitize resistant bacteria to methicillin and vancomycin . Clement Opoku-Temeng, Neetu Dayal, Jacob Miller, Herman O. Sintim
, RSC Adv.
, 2017
, 7
, 8288